Acute gout during treatment with paclitaxel for metastatic melanoma.
نویسندگان
چکیده
MOTOHISA YAMAMOTO, HIROKI TAKAHASHI, KOHHEI HASEBE, CHISAKO SUZUKI, YASUYOSHI NAISHIRO, TOSHIAKI HAYASHI, HIROYUKI YAMAMOTO, TADAO ISHIDA, YASUHISA SHINOMURA First Department of Internal Medicine, Sapporo Medical University School of Medicine, Department of General Internal Medicine, Teine Keijinkai Hospital and Biomedical Research Center, Department of Biomedical Engineering, Sapporo Medical University School of Medicine, Sapporo, Japan Accepted 25 March 2009 Correspondence to: Motohisa Yamamoto, First Department of Internal Medicine, Sapporo Medical University School of Medicine, South 1West 16, Chuo-ku, Sapporo, Hokkaido 060-8543, Japan. E-mail: [email protected]
منابع مشابه
Metastatic Melanoma (Secondary Malignancy) after Recovery from Acute Lymphoblastic Leukemia in a 10-year-old Girl: a case report
Acute lymphoblastic leukemia is the most common malignancy in children with a 5-year survival rate, accounting for 80% of cases. Melanoma is rare in children and has been reported as a sporadically occurring secondary malignant neoplasm in children with acute lymphoblastic leukemia. This study presented a 10-year-old Iranian child with pre-B-cell acute lymphoblastic leukemia that was diagnosed ...
متن کاملاثر تجویز نانوذره اکسید روی برکاهش بروز درد نوروپاتیک حرارتی ناشی از تجویز حاد و مزمن پاکلی تاکسل در موش های سوری
Background & Aims: Multiple evidences available about zinc oxide nanoparticles (nano-ZnO) ameliorative effects on neuroinflammation that worked in contrast to mechanisms activate with paclitaxel. In this study, effect of local and intraperitoneal application of nano-ZnO on paclitaxel-induced acute and chronic thermal hyperalgesia in mice was evaluated. Materials & Methods: Adult male mic...
متن کاملEffectiveness of Carboplatin and Paclitaxel as First- and Second-Line Treatment in 61 Patients with Metastatic Melanoma
BACKGROUND Patients with metastatic melanoma have a very unfavorable prognosis with few therapeutic options. Based on previous promising experiences within a clinical trial involving carboplatin and paclitaxel a series of advanced metastatic melanoma patients were treated with this combination. METHODS Data of all patients with cutaneous metastatic melanoma treated with carboplatin and paclit...
متن کاملAdvances in the systemic treatment of metastatic melanoma.
Prior to 2011, the only commercially available agents commonly used to treat metastatic melanoma-including dacarbazine, temozolomide (Temodar), fotemustine, carboplatin, paclitaxel, and interleukin-2-demonstrated limited efficacy, and no study involving these agents had shown an improvement in overall survival. The standard of care for the treatment of metastatic melanoma was radically changed ...
متن کاملA randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma.
BACKGROUND The efficacy and safety of nab-paclitaxel versus dacarbazine in patients with metastatic melanoma was evaluated in a phase III randomized, controlled trial. PATIENTS AND METHODS Chemotherapy-naïve patients with stage IV melanoma received nab-paclitaxel 150 mg/m(2) on days 1, 8, and 15 every 4 weeks or dacarbazine 1000 mg/m(2) every 3 weeks. The primary end point was progression-fre...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Rheumatology
دوره 48 7 شماره
صفحات -
تاریخ انتشار 2009